The greatest problem in the treatment of prostate cancer is the resistance of these cells to treatment aimed at inducing apoptosis, controlling signaling pathways responsible for cell proliferation or modulating the activity of the androgen receptor. The gene discussed is AR; the disease is prostate carcinoma.